FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> vertex | Resignation | Joshua Boger

Vertex CEO nails multimillion-dollar exit deal

Tools

Just a few days before Vertex CEO Joshua Boger (photo) announced plans to step down in May, he worked out a new "transition agreement" that's worth millions of dollars. While the company owed him no severance pay under his original employment agreement, Vertex will now hand over $2.85 million in cash in November while accelerating his stock vesting schedule and stock awards--which the Boston Globe notes could be worth millions more.

"It's an acknowledgement of [Boger's] service and advice going forward," Vertex spokeswoman Jane Kramer tells the Globe. Boger is leaving the top job at the company, but will remain on the board. His successor at Vertex, Matthew Emmens, will start with a salary of $1.1 million and an annual bonus target set at 115 percent of pay.

- read the story from the Boston Globe

Related Articles:
Vertex CEO resigns as telaprevir advances
Vertex readies new Phase 3 trial of telaprevir
Vertex shares rise on positive data for telaprevir
Vertex shares jump on positive telaprevir data


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about vertex   Resignation   Joshua Boger